Key Takeaways
- • Catalio Capital Management appointed Pasquale Chiacchiari as Principal and Head of Data Science, a newly created role, marking a strategic expansion into AI and machine learning capabilities for the healthcare-focused investment firm.
- • Chiacchiari brings elite quantitative and investment experience from Citadel Investment Group, Coatue Management, and most recently Freestone Grove Partners, where he bridged quantitative and fundamental investing as a quantitative equity researcher.
- • Catalio Capital closed Fund IV at $400 million earlier in 2026, bringing total assets under management above $1.5 billion, positioning the firm to operationalize advanced data science across its full lifecycle healthcare investment strategy spanning private, public, and credit markets.
- • The hire underscores Catalio's strategic focus on building "human-augmented investment platforms" that integrate artificial intelligence with fundamental analysis in life sciences investing, differentiating the firm in a competitive healthcare investment landscape.
- • Chiacchiari holds advanced credentials including an MS in Quantitative Finance from Princeton University and a BS in Finance and Economics from Bocconi University, complementing his career trajectory across top-tier asset managers.
Summary
Catalio Capital Management has elevated its quantitative and artificial intelligence capabilities by appointing Pasquale Chiacchiari as Principal and Head of Data Science, a newly created position at the New York-based specialist healthcare investment firm. The hire represents a deliberate strategic expansion as Catalio scales its operations following the successful close of Fund IV at $400 million earlier in 2026, which raised the firm's total assets under management above $1.5 billion.
Chiacchiari brings substantial experience from leading quantitative and hedge fund environments. Most recently, he served as a quantitative equity researcher at Freestone Grove Partners, a long/short equity hedge fund where he bridged quantitative modeling and fundamental investing approaches. His career includes tenures at Citadel Investment Group and Coatue Management, two of the industry's most sophisticated investment platforms, as well as earlier experience at JPMorgan Asset Management. His educational background includes an MS in Quantitative Finance from Princeton University and a BS in Finance and Economics from Bocconi University in Milan, providing both theoretical rigor and applied financial expertise.
In his new role, Chiacchiari will lead Catalio's data science function and spearhead the expansion of artificial intelligence capabilities across the firm's investment platform. Catalio's stated strategic direction emphasizes building "human-augmented investment platforms" that integrate advanced analytics with human judgment, rather than pursuing fully automated decision-making. This approach aligns with broader institutional investor trends toward responsible AI deployment in portfolio construction and monitoring.
Catalio Capital was founded in 2020 by George Petrocheilos and R. Jacob Vogelstein, both Johns Hopkins University alumni who previously worked together at Camden Partners. The firm invests across the full lifecycle of innovative healthcare companies, spanning private equity, public equity, and credit markets. Recent portfolio additions include medical supplies firm Cresilon, digital health platforms b.well Connected and Imperative Care, ProSomnus Sleep Technologies, and other life sciences ventures. Petrocheilos previously cofounded Camden Nexus, Johns Hopkins' specialized biomedical technology investment vehicle, and brings substantial healthcare sector expertise alongside board roles at Kennedy Krieger Institute and Johns Hopkins Center for Financial Economics.
## JSON METADATA
Chiacchiari brings substantial experience from leading quantitative and hedge fund environments. Most recently, he served as a quantitative equity researcher at Freestone Grove Partners, a long/short equity hedge fund where he bridged quantitative modeling and fundamental investing approaches. His career includes tenures at Citadel Investment Group and Coatue Management, two of the industry's most sophisticated investment platforms, as well as earlier experience at JPMorgan Asset Management. His educational background includes an MS in Quantitative Finance from Princeton University and a BS in Finance and Economics from Bocconi University in Milan, providing both theoretical rigor and applied financial expertise.
In his new role, Chiacchiari will lead Catalio's data science function and spearhead the expansion of artificial intelligence capabilities across the firm's investment platform. Catalio's stated strategic direction emphasizes building "human-augmented investment platforms" that integrate advanced analytics with human judgment, rather than pursuing fully automated decision-making. This approach aligns with broader institutional investor trends toward responsible AI deployment in portfolio construction and monitoring.
Catalio Capital was founded in 2020 by George Petrocheilos and R. Jacob Vogelstein, both Johns Hopkins University alumni who previously worked together at Camden Partners. The firm invests across the full lifecycle of innovative healthcare companies, spanning private equity, public equity, and credit markets. Recent portfolio additions include medical supplies firm Cresilon, digital health platforms b.well Connected and Imperative Care, ProSomnus Sleep Technologies, and other life sciences ventures. Petrocheilos previously cofounded Camden Nexus, Johns Hopkins' specialized biomedical technology investment vehicle, and brings substantial healthcare sector expertise alongside board roles at Kennedy Krieger Institute and Johns Hopkins Center for Financial Economics.
## JSON METADATA
Go deeper than the headline
Research every firm in this story, track the ones that matter and get the daily briefing — free for 7 days.